# Risk: __Cost and practicability of clinical testing and WBE__ (PBN__Risk_1449)

## Property: has_RiskISO_Impact

* [Community infrastructures](../RiskISO/PBN__RiskISO_Purpose_9)

## Property: has_RiskTechnology

* [none](../Technology/PBN__Technology_35)

## Property: has_RiskSubject

* [general population](../Stakeholder/PBN__Stakeholder_9)

## Property: has_RiskType

* [economic](../RiskType/PBN__RiskType_3)

## Property: has_RiskISO_Purpose

* [Resilience](../RiskISO/PBN__RiskISO_Impact_2)

## Property: has_RiskOwner

* [municipalities](../Stakeholder/PBN__Stakeholder_493)
* [public health agencies](../Stakeholder/PBN__Stakeholder_222)

## Property: has_RiskMitigation

* [Implement WBE surveillance as a cost-effective and rapid tool for population health assessment and monitoring.](../RiskMitigation/PBN__RiskMitigation_1961)

## Property: has_RiskName

Clinical testing is costly and impractical for population-wide testing, causing delays in assessing infection status.

## Property: has_RiskDescription

Clinical testing of individuals for COVID-19 is expensive and slow, while wastewater-based epidemiology (WBE) offers a rapid and cost-effective alternative.

## Property: has_RiskSource

* [hart_computational_2020](../Article/PBN__Article_252)

## Property: has_RiskGBN

* [Yes](../RiskGBN/PBN__RiskGBN_1)

## Property: has_RiskHealth

* [physical](../RiskHealth/PBN__RiskHealth_0)

